Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Cureus|September 22, 2025
Type I Cryoglobulinemia Associated With Multiple Myeloma: A Case ReportOdalyvianey Reyes-Báez, Ana L Carrillo-González, Salma Triana-González, et al.Revista Medica Del Instituto Mexicano Del Seguro Social|April 25, 2025
[Cryptococcus albidus, Naganishia albida, primary skin infection, first case reported in Mexico]María Fernanda Corona-Rosas, Aurora Paola Cruz Alcalá-Alegría, Salma Triana-González, et al.International Journal of STD & AIDS|September 27, 2024
Incidence of non-alcoholic fatty liver disease in antiretroviral therapy-naïve people with human immunodeficiency virus who start DTG/ABC/3TC compared to BIC/FTC/TAF at 48-week follow-upAna Luz Cano Díaz, Salma Triana González, Gloria Elizabeth Salinas Velázquez, et al.Journal of Cardiology Cases|May 18, 2022
A survivor woman after three years of a cardiac tamponadeAna Lilia Peralta-Amaro, Adriana Vázquez-Hernández, Guadalupe Morales-Osorio, et al.Viruses|November 27, 2024
Effectiveness of Direct Antiviral Agents in People with HCV-Monoinfection Compared to HCV/HIV Coinfection in a Real Life SettingCristina Guadalupe Román López, Salma Triana González, Ana Luz Cano Díaz, et al.Revista Medica Del Instituto Mexicano Del Seguro Social|June 27, 2022
[Leuko-glycemic index in patients with ST elevation myocardial infarction]Juan Carlos Reyes-Villarreal, Joel Eduardo Morales-Gutiérrez, Berenice López-Zamora, et al.AIDS (London, England)|June 9, 2023
Risk factors for mortality and clinical presentation of monkeypoxSalma Triana-González, Cristina Román-López, Stefan Mauss, et al.AIDS (London, England)|June 6, 2025
Incidence of metabolic syndrome in people with HIV who start dolutegravir based-regimen compared with bictegravir based-regimen after 48 weeksJosé Antonio Mata Marín, Mara Soraya Rodríguez Evaristo, Ana Luz Cano Díaz, et al.Viruses|July 27, 2024
Reversibility of Neuropsychiatric Adverse Events after Switching to Darunavir/Cobicistat or Doravirine in Men on INSTI-Based RegimenJosé Antonio Mata-Marín, Carina Aurora Juárez-Contreras, Mara Soraya Rodríguez-Evaristo, et al.Journal of Clinical Medicine|July 29, 2025
Prevalence and Risk Factors of Latent Tuberculosis Infection Detected by IGRA in Patients with Immune-Mediated Inflammatory Diseases Before and During Biologic DMARD Therapy (TITAN Study)José Antonio Mata-Marín, Marisol Apaez-Iglesias, Ana Luz Cano-Díaz, et al.Pageof 2